PGAM2

UniProt ID: P15259
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

PGAM2 is the muscle (M) isoform of phosphoglycerate mutase, a cytosolic enzyme of the cofactor-dependent phosphoglycerate mutase (histidine-phosphatase) superfamily. It catalyzes the reversible interconversion of 3-phosphoglycerate and 2-phosphoglycerate, the eighth step of the glycolytic payoff phase (and the corresponding reverse step in gluconeogenesis). Catalysis proceeds through a phospho-histidine enzyme intermediate and requires 2,3-bisphosphoglycerate as a cofactor/primer; the enzyme also displays a minor bisphosphoglycerate mutase/phosphatase side activity. Active human phosphoglycerate mutase is a dimer assembled from muscle (PGAM2/M) and brain (PGAM1/B) subunits; skeletal muscle expresses essentially the PGAM2 homodimer, whereas erythrocytes express PGAM1. PGAM2 is expressed predominantly in heart and skeletal muscle. Loss-of-function variants cause glycogen storage disease type X (muscle phosphoglycerate mutase deficiency), manifesting as exercise intolerance, muscle cramps, and myoglobinuria/rhabdomyolysis.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004619 phosphoglycerate mutase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) assignment of the core catalytic activity of PGAM2: reversible interconversion of 3- and 2-phosphoglycerate. This is the defining molecular function of the muscle phosphoglycerate mutase subunit and is strongly corroborated by experimental and UniProt evidence.
Reason: Core molecular function, correct at the right level of specificity, and consistent across independent evidence lines (IBA, EXP, IMP, ISS, IEA) and the UniProt catalytic-activity record (EC 5.4.2.11).
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of the cytosol as the site of action. Phosphoglycerate mutase is a soluble cytosolic glycolytic enzyme, consistent with Reactome and UniProt.
Reason: Correct subcellular location for a soluble glycolytic enzyme; agrees with Reactome TAS cytosol annotations and with the entire glycolytic pathway being cytosolic.
Supporting Evidence:
Reactome:R-HSA-71445
Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate
GO:0061621 canonical glycolysis
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of PGAM2 to canonical glycolysis (the ATP-generating glucose-to-pyruvate route). PGAM catalyzes step 8 (3-PG to 2-PG) of the glycolytic payoff phase.
Reason: Core biological process for the muscle glycolytic isoform, at an appropriate level of specificity; corroborated by the Reactome Glycolysis pathway and by the IMP glycolytic-process annotation.
Supporting Evidence:
Reactome:R-HSA-70171
The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert
GO:0003824 catalytic activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Root-level InterPro2GO mapping asserting generic catalytic activity. Not incorrect but entirely uninformative given the specific mutase activity is already annotated.
Reason: "catalytic activity" is a top-level MF placeholder subsumed by the specific phosphoglycerate mutase activity annotation; it adds no functional information.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
GO:0004082 bisphosphoglycerate mutase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic mapping (EC 5.4.2.4 / RHEA:17765) of the minor bisphosphoglycerate mutase side activity. UniProt records that the enzyme "can also catalyze the interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl phosphate, but with a reduced activity."
Reason: Genuine, documented secondary catalytic activity of the BPG-dependent PGAM subfamily; correctly captured, though it is the reduced-activity side reaction rather than the primary physiological function.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC 3-phospho-glyceroyl phosphate, but with a reduced activity.
GO:0004619 phosphoglycerate mutase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic mapping (EC 5.4.2.11 / RHEA:15901 / ARBA) of the core phosphoglycerate mutase activity. Duplicate of the core MF from an automated pipeline.
Reason: Correct core molecular function; the automated EC/RHEA mapping agrees with the experimental and phylogenetic annotations.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
GO:0006096 glycolytic process
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment to the glycolytic process. Correct core pathway for PGAM2, also supported experimentally by the deficiency phenotype (IMP).
Reason: Core biological process; consistent with the IMP annotation from the muscle PGAM deficiency case and with the canonical-glycolysis annotations.
Supporting Evidence:
PMID:6262916
Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest
GO:0016868 intramolecular phosphotransferase activity
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro2GO mapping to intramolecular phosphotransferase activity, the isomerase parent class (EC 5.4.2.-) that includes phosphoglycerate mutase. Correct but more general than the specific mutase term already annotated.
Reason: Accurate parent-level molecular function; an IEA term is permitted to be broader than the specific mutase activity, and it correctly reflects the isomerase reaction chemistry (intramolecular phospho group transfer).
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: High-throughput AP-MS interactome (BioPlex 2.0) reporting a PGAM2-BPGM (P07738) co-complex. Bare "protein binding" is uninformative about molecular function.
Reason: Per curation guidance, bare "protein binding" is not an informative molecular function and this is an interactome-screen IPI. The recurrent BPGM partner is biologically plausible (both enzymes act on 2,3-bisphosphoglycerate) but does not itself define a specific molecular function; retained (not removed) as an experimental IPI.
Supporting Evidence:
PMID:28514442
BioPlex 2.0 is the largest collection of human co-complex data assembled from a single pipeline to date
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Binary interactome map (HuRI, yeast two-hybrid) reporting PGAM2 interactions (e.g. BPGM, CLVS2, DYNC1LI1, KATNAL1). Bare "protein binding" is uninformative.
Reason: Uninformative generic "protein binding" from a systematic binary-interactome screen; retained as an experimental IPI but not treated as a defining function.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: High-throughput AP-MS interactome (BioPlex 3.0) again reporting a PGAM2-BPGM (P07738) association. Bare "protein binding" is uninformative.
Reason: Generic "protein binding" from an interactome screen; consistent with the other BioPlex/HuRI evidence but non-specific; retained as an experimental IPI.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human
GO:0042802 identical protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
ACCEPT
Summary: Self-interaction of PGAM2 (P15259-P15259) detected in the binary interactome map, consistent with the established homodimeric quaternary structure of phosphoglycerate mutase.
Reason: Informative self-association annotation that matches the documented homodimer; UniProt SUBUNIT states "Homodimer" and Reactome describes the active enzyme as a dimer.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,
GO:0005634 nucleus
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Orthology-based (Ensembl Compara, from rat P16290) transfer of a nuclear localization. PGAM2 is a soluble cytosolic glycolytic enzyme; a nuclear location is not associated with any established nuclear function.
Reason: Nuclear localization is not part of the core biology of this cytosolic enzyme; it derives from orthology transfer plus proteomic detection in sperm nuclei and likely reflects contamination/moonlighting rather than a functional nuclear role.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,
GO:0005829 cytosol
IEA
GO_REF:0000107
ACCEPT
Summary: Orthology-based (Ensembl Compara, from mouse O70250) assignment of the cytosol as site of action. Correct core location for a glycolytic enzyme.
Reason: Agrees with the IBA and Reactome TAS cytosol annotations; correct compartment for phosphoglycerate mutase activity.
Supporting Evidence:
Reactome:R-HSA-71445
Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate
GO:0006094 gluconeogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Orthology-based (Ensembl Compara) assignment to gluconeogenesis. The phosphoglycerate mutase reaction is reversible and is shared with the gluconeogenic direction, but physiological gluconeogenesis is confined to liver and kidney, which express PGAM1 rather than the muscle PGAM2 isoform.
Reason: The reaction chemistry participates in gluconeogenesis, but the muscle isoform's core in-vivo role is glycolytic; muscle does not perform gluconeogenesis, so this is retained as a non-core, reaction-shared process rather than PGAM2's primary physiological function.
Supporting Evidence:
Reactome:R-HSA-70263
Gluconeogenesis is confined to cells of the liver and kidney
GO:0007283 spermatogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Orthology-based (Ensembl Compara, from rat P16290) transfer of a spermatogenesis role. Sperm rely heavily on glycolysis, but a direct role of the muscle PGAM2 isoform in spermatogenesis is not established in human.
Reason: Speculative context transferred by orthology; not a core molecular/biological function of the human muscle isoform. Retained as non-core rather than removed, since it is a plausible tissue context for a glycolytic enzyme.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- TISSUE SPECIFICITY: Expressed in the heart and muscle. Not found in the
GO:0046689 response to mercury ion
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Orthology-based (Ensembl Compara, from rat P16290) transfer of a "response to mercury ion" process. The M subunit is mercury-inhibitable in vitro (historically used to distinguish M from BB isozymes), but this is an enzyme-property observation, not a biological response process of human PGAM2.
Reason: "response to mercury ion" as a biological process is an orthology artifact and does not represent a core biological role of PGAM2; in-vitro Hg sensitivity of the catalytic His does not constitute a cellular mercury-response pathway.
Supporting Evidence:
PMID:6262916
Electrophoretic,
GO:0061621 canonical glycolysis
IEA
GO_REF:0000107
ACCEPT
Summary: Orthology-based (Ensembl Compara, from mouse O70250) assignment to canonical glycolysis. Correct core process; duplicate of the IBA/TAS glycolysis annotations.
Reason: Core glycolytic process for the muscle isoform, consistent with all other glycolysis evidence lines.
Supporting Evidence:
Reactome:R-HSA-70171
The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert
GO:1990917 ooplasm
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Orthology-based (Ensembl Compara, from rat P16290) transfer of an ooplasm (oocyte cytoplasm) location. This is a tissue-context transfer; the compartment (cytoplasm) is consistent with a cytosolic enzyme, but the specific ooplasmic localization is not established for the human muscle isoform.
Reason: Cytoplasmic location is consistent with PGAM2 biology, but "ooplasm" is an orthology-derived tissue-specific location not relevant to the muscle isoform's core role; retained as non-core rather than removed.
Supporting Evidence:
Reactome:R-HSA-71445
Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate
GO:0006094 gluconeogenesis
TAS
Reactome:R-HSA-70263
KEEP AS NON CORE
Summary: Reactome pathway annotation placing the reversible phosphoglycerate mutase reaction within gluconeogenesis. The reaction is genuinely part of the gluconeogenic sequence (a reverse-of-glycolysis step).
Reason: The PGAM reaction participates in the gluconeogenesis pathway as modeled by Reactome, so the annotation is not wrong; however gluconeogenesis is a liver/kidney process (PGAM1), so it is not the core physiological role of the muscle PGAM2 isoform. Retained as non-core.
Supporting Evidence:
Reactome:R-HSA-70263
Gluconeogenesis is confined to cells of the liver and kidney
GO:0061621 canonical glycolysis
TAS
Reactome:R-HSA-70171
ACCEPT
Summary: Reactome pathway annotation placing PGAM within canonical glycolysis (the cytosolic glucose-to-pyruvate route). Core process for PGAM2.
Reason: Authoritative pathway (TAS) annotation for the core glycolytic role; consistent with all other glycolysis evidence.
Supporting Evidence:
Reactome:R-HSA-70171
The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert
GO:0004619 phosphoglycerate mutase activity
EXP
PMID:4827367
Phosphoglycerate mutase isozyme marker for tissue differenti...
ACCEPT
Summary: Experimental annotation of phosphoglycerate mutase activity based on characterization of the human PGAM isozymes as tissue-differentiation markers (Omenn & Cheung 1974), which established the muscle (M) versus brain (B) subunit isozyme system.
Reason: Experimental support for the core catalytic activity of the muscle phosphoglycerate mutase isozyme; foundational isozyme-characterization work.
Supporting Evidence:
PMID:4827367
Phosphoglycerate mutase isozyme marker for tissue differentiation in man.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
MARK AS OVER ANNOTATED
Summary: Human Protein Atlas immunofluorescence (IDA) reporting nucleoplasmic signal. PGAM2 is an abundant soluble cytosolic enzyme; nucleoplasmic staining is not linked to any established nuclear function.
Reason: A single-technique IF localization for an abundant cytosolic glycolytic enzyme, without a corresponding nuclear function; likely reflects the diffuse distribution/permeabilization artifacts common for soluble enzymes rather than a core nucleoplasmic role.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,
GO:0004082 bisphosphoglycerate mutase activity
ISS
GO_REF:0000024
ACCEPT
Summary: Sequence-similarity transfer (from PGAM1, P18669) of the minor bisphosphoglycerate mutase activity. Consistent with the UniProt-documented reduced-activity side reaction of the BPG-dependent PGAM subfamily.
Reason: Genuine secondary catalytic activity supported by family membership and the UniProt catalytic-activity record (EC 5.4.2.4); appropriately marked as a similarity-based inference.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC 3-phospho-glyceroyl phosphate, but with a reduced activity.
GO:0004619 phosphoglycerate mutase activity
ISS
GO_REF:0000024
ACCEPT
Summary: Sequence-similarity transfer (from PGAM1, P18669) of the core phosphoglycerate mutase activity. Duplicate of the well-supported core MF.
Reason: Correct core molecular function; the ISS inference agrees with experimental, phylogenetic, and automated evidence.
Supporting Evidence:
file:human/PGAM2/PGAM2-uniprot.txt
CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
GO:0070062 extracellular exosome
HDA
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expres...
MARK AS OVER ANNOTATED
Summary: High-throughput proteomic detection in exosomes from expressed prostatic secretions in urine. PGAM2 is a ubiquitous soluble cytosolic enzyme that commonly co-purifies in exosome/secretome proteomes.
Reason: A single high-throughput exosome-proteome detection does not establish extracellular exosome as a functional location for this cytosolic glycolytic enzyme; frequent contaminant in such datasets.
Supporting Evidence:
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expressed prostatic
GO:0005634 nucleus
HDA
PMID:21630459
Proteomic characterization of the human sperm nucleus.
MARK AS OVER ANNOTATED
Summary: High-throughput proteomic detection of PGAM in isolated human sperm nuclei. Nuclear detection of an abundant soluble glycolytic enzyme in a whole-organelle proteome does not establish a functional nuclear role.
Reason: Proteomic co-detection in a sperm-nucleus preparation is prone to soluble-enzyme carryover; there is no established nuclear function for PGAM2, so this is an over-annotation of its core cytosolic biology.
Supporting Evidence:
PMID:21630459
sperm nuclei were obtained
GO:0005829 cytosol
TAS
Reactome:R-HSA-71445
ACCEPT
Summary: Reactome TAS annotation of the cytosol as the location where PGAM dimers isomerise 2PG to 3PG. Core, correct location.
Reason: Authoritative pathway annotation of the correct compartment for a cytosolic glycolytic enzyme.
Supporting Evidence:
Reactome:R-HSA-71445
Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate
GO:0005829 cytosol
TAS
Reactome:R-HSA-71654
ACCEPT
Summary: Reactome TAS annotation of the cytosol as the location where PGAM dimers isomerise 3PG to 2PG. Core, correct location (duplicate direction of the same reversible reaction).
Reason: Authoritative pathway annotation of the correct cytosolic compartment.
Supporting Evidence:
Reactome:R-HSA-71654
Cytosolic phosphoglycerate mutase catalyzes the reversible isomerisation
GO:0004619 phosphoglycerate mutase activity
IMP
PMID:6262916
Human muscle phosphoglycerate mutase deficiency: newly disco...
ACCEPT
Summary: Experimental (IMP) support from the first described human muscle phosphoglycerate mutase deficiency: muscle PGAM activity was reduced to 5.7% of the lowest control value, with the residual activity being the brain (BB) isoenzyme, implicating loss of the M subunit encoded by PGAM2.
Reason: Direct genetic/biochemical evidence in humans that PGAM2 provides phosphoglycerate mutase activity in muscle; the disease phenotype tracks the loss of M-subunit activity.
Supporting Evidence:
PMID:6262916
Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest
GO:0006096 glycolytic process
IMP
PMID:6262916
Human muscle phosphoglycerate mutase deficiency: newly disco...
ACCEPT
Summary: Experimental (IMP) support that PGAM2 functions in glycolysis: the muscle PGAM deficiency produces a block at the phosphoglycerate mutase step of glycolysis while all other glycolytic enzymes had normal activities.
Reason: Human loss-of-function evidence directly linking PGAM2 to the glycolytic process; the specific enzymatic block defines its glycolytic role.
Supporting Evidence:
PMID:6262916
All of the other enzymes of glycolysis
GO:0006941 striated muscle contraction
IMP
PMID:6262916
Human muscle phosphoglycerate mutase deficiency: newly disco...
MARK AS OVER ANNOTATED
Summary: Annotation to striated muscle contraction derived from the muscle PGAM deficiency phenotype (exercise intolerance, cramps, pigmenturia). PGAM2 is a glycolytic enzyme, not a component of the contractile apparatus.
Reason: Exercise intolerance and cramps in PGAM deficiency are downstream consequences of impaired muscle glycolytic ATP supply, not evidence that PGAM2 participates directly in the muscle-contraction process; the causal role is glycolysis. This is an over-annotation of a phenotype (retained rather than removed as it derives from an experimental report).
Supporting Evidence:
PMID:6262916
intolerance for strenuous exercise and

Core Functions

Catalyzes the reversible, 2,3-bisphosphoglycerate-dependent interconversion of 3-phosphoglycerate and 2-phosphoglycerate via a phospho-histidine intermediate, the eighth step of glycolysis, in the cytosol of skeletal and cardiac muscle.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • file:human/PGAM2/PGAM2-uniprot.txt
    CC -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate
  • PMID:6262916
    Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Proteomic characterization of the human sperm nucleus.
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Architecture of the human interactome defines protein communities and disease networks.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Phosphoglycerate mutase isozyme marker for tissue differentiation in man.
Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy.
Reactome:R-HSA-70171
Glycolysis
Reactome:R-HSA-70263
Gluconeogenesis
Reactome:R-HSA-71445
PGAM dimers isomerise 2PG to 3PG
Reactome:R-HSA-71654
PGAM dimers isomerise 3PG to 2PG
file:human/PGAM2/PGAM2-uniprot.txt
UniProt entry P15259 (PGAM2_HUMAN)

📚 Additional Documentation

Notes

(PGAM2-notes.md)

PGAM2 (human) — gene review notes

UniProtKB: P15259 (PGAM2_HUMAN). HGNC:8889. Gene on chromosome 7.
Synonyms: PGAMM; "muscle-specific phosphoglycerate mutase"; "phosphoglycerate mutase isozyme M" (PGAM-M).

Core biology (from PGAM2-uniprot.txt and Reactome)

  • PGAM2 is the muscle (M) subunit of phosphoglycerate mutase, a member of the
    cofactor-dependent phosphoglycerate mutase / histidine-phosphatase superfamily
    (BPG-dependent PGAM subfamily). UniProt SIMILARITY: "Belongs to the phosphoglycerate
    mutase family. BPG-dependent PGAM subfamily."
  • FUNCTION (UniProt): "Catalyzes the interconversion of 3- and 2-phosphoglycerate with
    2,3-bisphosphoglycerate as the primer of the reaction. Can also catalyze the
    interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl phosphate,
    but with a reduced activity." → primary EC 5.4.2.11 (PGAM, GO:0004619); minor
    EC 5.4.2.4 (bisphosphoglycerate mutase, GO:0004082).
  • Mechanism: phospho-histidine intermediate. ACT_SITE 11 = "Tele-phosphohistidine
    intermediate"; ACT_SITE 89 = "Proton donor/acceptor". Catalytic His at position 11 is
    the classic His-phosphatase-fold catalytic residue; 2,3-BPG is the required cofactor/primer.
  • Reaction (Rhea:RHEA:15901): (2R)-2-phosphoglycerate = (2R)-3-phosphoglycerate. Reversible;
    step 8 of the glycolytic payoff phase (3-PG → 2-PG going toward pyruvate) and the reverse
    step in gluconeogenesis.
  • Cytosolic. Human PGAM is a dimer of M (PGAM2) and B (PGAM1) subunits; muscle is
    essentially the PGAM2 homodimer (SUBUNIT: "Homodimer"). Reactome R-HSA-71445/71654:
    "erythrocytes express only PGAM1, while skeletal muscle expresses only PGAM2."
  • TISSUE SPECIFICITY (UniProt, PubMed:2822696): "Expressed in the heart and muscle. Not
    found in the liver and brain." HPA: group-enriched heart muscle, skeletal muscle, tongue.

Disease

  • Glycogen storage disease X (GSD10 / GSD X); muscle phosphoglycerate mutase deficiency
    (MIM:261670). UniProt DISEASE: "characterized by myoglobinuria, increased serum creatine
    kinase levels, decreased phosphoglycerate mutase activity, myalgia, muscle pain, muscle
    cramps, exercise intolerance." Variants: Glu89Ala, Arg90Trp (PubMed:8447317), Gly97Asp
    (PubMed:10545043).
  • Original clinical description: DiMauro et al. 1981 (PMID:6262916) — first human muscle
    PGAM deficiency: muscle PGAM activity 5.7% of lowest control in a patient with exercise
    intolerance and recurrent pigmenturia (myoglobinuria); residual activity was the brain
    (BB) isoenzyme, "suggesting a genetic defect of the M subunit which predominates in
    normal muscle." This grounds the IMP GO:0004619 / GO:0006096 annotations. The
    striated-muscle-contraction annotation (GO:0006941) from the same paper is a phenotype
    (exercise intolerance/cramps) rather than a direct role of PGAM2 in the contractile
    mechanism → MARK_AS_OVER_ANNOTATED.

GO annotation assessment summary

Molecular function — CORE:
- GO:0004619 phosphoglycerate mutase activity: multiply supported (IBA, IEA×2, EXP, ISS, IMP).
ACCEPT the well-grounded ones (IBA anchor; EXP PMID:4827367 isozyme/enzyme-marker; IMP
PMID:6262916 deficiency). This is the core MF.
- GO:0004082 bisphosphoglycerate mutase activity (IEA GO_REF:0000120 EC 5.4.2.4; ISS
GO_REF:0000024 from PGAM1 P18669): real minor/secondary activity per UniProt FUNCTION.
ACCEPT but note it is the reduced-activity side reaction, not the core physiological role.
- GO:0016868 intramolecular phosphotransferase activity (IEA InterPro): correct parent
(isomerase EC 5.4.2.-); a bit general → ACCEPT (IEA allowed to be broader).
- GO:0003824 catalytic activity (IEA InterPro): root-level, uninformative but not wrong.
MARK_AS_OVER_ANNOTATED (root filler).
- GO:0005515 protein binding (IPI ×3: PMID:28514442 BioPlex2, PMID:33961781 BioPlex3,
PMID:32296183 HuRI). Bare "protein binding" is uninformative. Per policy: do NOT REMOVE
IPI protein-binding; MARK_AS_OVER_ANNOTATED. Note the recurrent BPGM (P07738) partner is
biologically sensible (both act on 2,3-BPG / glycerate phosphates).
- GO:0042802 identical protein binding (IPI PMID:32296183, self P15259): consistent with
the documented homodimer → ACCEPT (informative self-association / dimerisation).

Biological process:
- GO:0006096 glycolytic process (IEA GO_REF:0000120; IMP PMID:6262916): core. ACCEPT.
- GO:0061621 canonical glycolysis (IBA; IEA GO_REF:0000107; TAS Reactome): more specific
glycolysis child, core. ACCEPT (IBA).
- GO:0006094 gluconeogenesis (IEA Ensembl; TAS Reactome R-HSA-70263): PGAM catalyses the
reversible step also used in gluconeogenesis. Physiologically gluconeogenesis is
liver/kidney (which express PGAM1, not PGAM2 — muscle does not do gluconeogenesis).
Reaction chemistry is shared but the muscle isoform's physiological role is glycolysis.
Keep the Reactome TAS as ACCEPT (reaction participates in the pathway) and KEEP_AS_NON_CORE
for the Ensembl-orthology IEA (not the muscle isoform's core in-vivo role).
- GO:0007283 spermatogenesis (IEA Ensembl, from rat P16290): orthology-transfer, not a
direct PGAM2 function; sperm express glycolytic enzymes but this is a phenotypic/context
transfer. KEEP_AS_NON_CORE.
- GO:0046689 response to mercury ion (IEA Ensembl, rat P16290): PGAM M subunit is
Hg-inhibitable (DiMauro 1981 used mercury inhibition to distinguish M vs BB isozymes),
but "response to mercury ion" as a BP is an orthology artifact, not a core biological role
→ MARK_AS_OVER_ANNOTATED.
- GO:0006941 striated muscle contraction (IMP PMID:6262916): the deficiency causes
exercise intolerance/cramps, but PGAM2 is not part of the contractile machinery; this is
a downstream phenotype → MARK_AS_OVER_ANNOTATED.

Cellular component:
- GO:0005829 cytosol (IBA; IEA GO_REF:0000107; TAS Reactome ×2): core location. ACCEPT (IBA).
- GO:0005634 nucleus (IEA Ensembl; HDA PMID:21630459 sperm-nucleus proteome): proteomic
detection in isolated sperm nuclei; likely soluble-enzyme contamination / not the site of
its enzymatic action → MARK_AS_OVER_ANNOTATED.
- GO:0005654 nucleoplasm (IDA HPA immunofluorescence, GO_REF:0000052): HPA IF; abundant
glycolytic enzyme, nuclear signal not linked to a nuclear function → MARK_AS_OVER_ANNOTATED.
- GO:1990917 ooplasm (IEA Ensembl, rat P16290): orthology transfer to oocyte cytoplasm;
not established for human muscle isoform → KEEP_AS_NON_CORE (it is still cytoplasm).
- GO:0070062 extracellular exosome (HDA PMID:23533145 prostatic-secretion exosomes):
high-throughput exosome proteome; ubiquitous cytosolic enzyme frequently co-purifies →
MARK_AS_OVER_ANNOTATED.

Interactome partners (from UniProt INTERACTION + IPI refs)

  • BPGM P07738 (bisphosphoglycerate mutase) — recurrent, NbExp=6; biologically related enzyme.
  • CLVS2 Q5SYC1, DYNC1LI1 Q9Y6G9, KATNAL1 Q9BW62 — Y2H/AP-MS partners, unclear functional link.
  • PGAM2 P15259 self — homodimer.
    These support only generic protein binding + identical protein binding; no informative
    complex/adapter MF is warranted.

Deep research

falcon deep-research provider is OUT OF CREDITS (HTTP 402) at review time; no
-deep-research-falcon.md was generated. Review grounded in UniProt (P15259), the seeded GOA,
cached PMIDs, and cached Reactome entries.

📄 View Raw YAML

id: P15259
gene_symbol: PGAM2
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  PGAM2 is the muscle (M) isoform of phosphoglycerate mutase, a cytosolic enzyme
  of the cofactor-dependent phosphoglycerate mutase (histidine-phosphatase)
  superfamily. It catalyzes the reversible interconversion of 3-phosphoglycerate
  and 2-phosphoglycerate, the eighth step of the glycolytic payoff phase (and the
  corresponding reverse step in gluconeogenesis). Catalysis proceeds through a
  phospho-histidine enzyme intermediate and requires 2,3-bisphosphoglycerate as a
  cofactor/primer; the enzyme also displays a minor bisphosphoglycerate
  mutase/phosphatase side activity. Active human phosphoglycerate mutase is a
  dimer assembled from muscle (PGAM2/M) and brain (PGAM1/B) subunits; skeletal
  muscle expresses essentially the PGAM2 homodimer, whereas erythrocytes express
  PGAM1. PGAM2 is expressed predominantly in heart and skeletal muscle.
  Loss-of-function variants cause glycogen storage disease type X (muscle
  phosphoglycerate mutase deficiency), manifesting as exercise intolerance,
  muscle cramps, and myoglobinuria/rhabdomyolysis.
existing_annotations:
- term:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) assignment of the core catalytic activity of PGAM2:
      reversible interconversion of 3- and 2-phosphoglycerate. This is the
      defining molecular function of the muscle phosphoglycerate mutase subunit
      and is strongly corroborated by experimental and UniProt evidence.
    action: ACCEPT
    reason: >-
      Core molecular function, correct at the right level of specificity, and
      consistent across independent evidence lines (IBA, EXP, IMP, ISS, IEA) and
      the UniProt catalytic-activity record (EC 5.4.2.11).
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic assignment of the cytosol as the site of action. Phosphoglycerate
      mutase is a soluble cytosolic glycolytic enzyme, consistent with Reactome and
      UniProt.
    action: ACCEPT
    reason: >-
      Correct subcellular location for a soluble glycolytic enzyme; agrees with
      Reactome TAS cytosol annotations and with the entire glycolytic pathway being
      cytosolic.
    supported_by:
    - reference_id: Reactome:R-HSA-71445
      supporting_text: "Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate"
- term:
    id: GO:0061621
    label: canonical glycolysis
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic assignment of PGAM2 to canonical glycolysis (the ATP-generating
      glucose-to-pyruvate route). PGAM catalyzes step 8 (3-PG to 2-PG) of the
      glycolytic payoff phase.
    action: ACCEPT
    reason: >-
      Core biological process for the muscle glycolytic isoform, at an appropriate
      level of specificity; corroborated by the Reactome Glycolysis pathway and by
      the IMP glycolytic-process annotation.
    supported_by:
    - reference_id: Reactome:R-HSA-70171
      supporting_text: "The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert"
- term:
    id: GO:0003824
    label: catalytic activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Root-level InterPro2GO mapping asserting generic catalytic activity. Not
      incorrect but entirely uninformative given the specific mutase activity is
      already annotated.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      "catalytic activity" is a top-level MF placeholder subsumed by the specific
      phosphoglycerate mutase activity annotation; it adds no functional information.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
- term:
    id: GO:0004082
    label: bisphosphoglycerate mutase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic mapping (EC 5.4.2.4 / RHEA:17765) of the minor bisphosphoglycerate
      mutase side activity. UniProt records that the enzyme "can also catalyze the
      interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl
      phosphate, but with a reduced activity."
    action: ACCEPT
    reason: >-
      Genuine, documented secondary catalytic activity of the BPG-dependent PGAM
      subfamily; correctly captured, though it is the reduced-activity side reaction
      rather than the primary physiological function.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC       3-phospho-glyceroyl phosphate, but with a reduced activity."
- term:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic mapping (EC 5.4.2.11 / RHEA:15901 / ARBA) of the core
      phosphoglycerate mutase activity. Duplicate of the core MF from an automated
      pipeline.
    action: ACCEPT
    reason: >-
      Correct core molecular function; the automated EC/RHEA mapping agrees with the
      experimental and phylogenetic annotations.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
- term:
    id: GO:0006096
    label: glycolytic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: >-
      Electronic assignment to the glycolytic process. Correct core pathway for
      PGAM2, also supported experimentally by the deficiency phenotype (IMP).
    action: ACCEPT
    reason: >-
      Core biological process; consistent with the IMP annotation from the muscle
      PGAM deficiency case and with the canonical-glycolysis annotations.
    supported_by:
    - reference_id: PMID:6262916
      supporting_text: "Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest"
- term:
    id: GO:0016868
    label: intramolecular phosphotransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro2GO mapping to intramolecular phosphotransferase activity, the
      isomerase parent class (EC 5.4.2.-) that includes phosphoglycerate mutase.
      Correct but more general than the specific mutase term already annotated.
    action: ACCEPT
    reason: >-
      Accurate parent-level molecular function; an IEA term is permitted to be
      broader than the specific mutase activity, and it correctly reflects the
      isomerase reaction chemistry (intramolecular phospho group transfer).
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      High-throughput AP-MS interactome (BioPlex 2.0) reporting a PGAM2-BPGM
      (P07738) co-complex. Bare "protein binding" is uninformative about molecular
      function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Per curation guidance, bare "protein binding" is not an informative molecular
      function and this is an interactome-screen IPI. The recurrent BPGM partner is
      biologically plausible (both enzymes act on 2,3-bisphosphoglycerate) but does
      not itself define a specific molecular function; retained (not removed) as an
      experimental IPI.
    supported_by:
    - reference_id: PMID:28514442
      supporting_text: "BioPlex 2.0 is the largest collection of human co-complex data assembled from a single pipeline to date"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      Binary interactome map (HuRI, yeast two-hybrid) reporting PGAM2 interactions
      (e.g. BPGM, CLVS2, DYNC1LI1, KATNAL1). Bare "protein binding" is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative generic "protein binding" from a systematic binary-interactome
      screen; retained as an experimental IPI but not treated as a defining function.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: "A reference map of the human binary protein interactome."
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      High-throughput AP-MS interactome (BioPlex 3.0) again reporting a PGAM2-BPGM
      (P07738) association. Bare "protein binding" is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Generic "protein binding" from an interactome screen; consistent with the
      other BioPlex/HuRI evidence but non-specific; retained as an experimental IPI.
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: "Dual proteome-scale networks reveal cell-specific remodeling of the human"
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      Self-interaction of PGAM2 (P15259-P15259) detected in the binary interactome
      map, consistent with the established homodimeric quaternary structure of
      phosphoglycerate mutase.
    action: ACCEPT
    reason: >-
      Informative self-association annotation that matches the documented homodimer;
      UniProt SUBUNIT states "Homodimer" and Reactome describes the active enzyme as
      a dimer.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,"
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: located_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from rat P16290) transfer of a nuclear
      localization. PGAM2 is a soluble cytosolic glycolytic enzyme; a nuclear
      location is not associated with any established nuclear function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Nuclear localization is not part of the core biology of this cytosolic enzyme;
      it derives from orthology transfer plus proteomic detection in sperm nuclei and
      likely reflects contamination/moonlighting rather than a functional nuclear role.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: is_active_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from mouse O70250) assignment of the cytosol
      as site of action. Correct core location for a glycolytic enzyme.
    action: ACCEPT
    reason: >-
      Agrees with the IBA and Reactome TAS cytosol annotations; correct compartment
      for phosphoglycerate mutase activity.
    supported_by:
    - reference_id: Reactome:R-HSA-71445
      supporting_text: "Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate"
- term:
    id: GO:0006094
    label: gluconeogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara) assignment to gluconeogenesis. The
      phosphoglycerate mutase reaction is reversible and is shared with the
      gluconeogenic direction, but physiological gluconeogenesis is confined to
      liver and kidney, which express PGAM1 rather than the muscle PGAM2 isoform.
    action: KEEP_AS_NON_CORE
    reason: >-
      The reaction chemistry participates in gluconeogenesis, but the muscle isoform's
      core in-vivo role is glycolytic; muscle does not perform gluconeogenesis, so this
      is retained as a non-core, reaction-shared process rather than PGAM2's primary
      physiological function.
    supported_by:
    - reference_id: Reactome:R-HSA-70263
      supporting_text: "Gluconeogenesis is confined to cells of the liver and kidney"
- term:
    id: GO:0007283
    label: spermatogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from rat P16290) transfer of a spermatogenesis
      role. Sperm rely heavily on glycolysis, but a direct role of the muscle PGAM2
      isoform in spermatogenesis is not established in human.
    action: KEEP_AS_NON_CORE
    reason: >-
      Speculative context transferred by orthology; not a core molecular/biological
      function of the human muscle isoform. Retained as non-core rather than removed,
      since it is a plausible tissue context for a glycolytic enzyme.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- TISSUE SPECIFICITY: Expressed in the heart and muscle. Not found in the"
- term:
    id: GO:0046689
    label: response to mercury ion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from rat P16290) transfer of a
      "response to mercury ion" process. The M subunit is mercury-inhibitable in vitro
      (historically used to distinguish M from BB isozymes), but this is an
      enzyme-property observation, not a biological response process of human PGAM2.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      "response to mercury ion" as a biological process is an orthology artifact and
      does not represent a core biological role of PGAM2; in-vitro Hg sensitivity of the
      catalytic His does not constitute a cellular mercury-response pathway.
    supported_by:
    - reference_id: PMID:6262916
      supporting_text: "Electrophoretic, "
- term:
    id: GO:0061621
    label: canonical glycolysis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from mouse O70250) assignment to canonical
      glycolysis. Correct core process; duplicate of the IBA/TAS glycolysis
      annotations.
    action: ACCEPT
    reason: >-
      Core glycolytic process for the muscle isoform, consistent with all other
      glycolysis evidence lines.
    supported_by:
    - reference_id: Reactome:R-HSA-70171
      supporting_text: "The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert"
- term:
    id: GO:1990917
    label: ooplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: located_in
  review:
    summary: >-
      Orthology-based (Ensembl Compara, from rat P16290) transfer of an ooplasm
      (oocyte cytoplasm) location. This is a tissue-context transfer; the compartment
      (cytoplasm) is consistent with a cytosolic enzyme, but the specific ooplasmic
      localization is not established for the human muscle isoform.
    action: KEEP_AS_NON_CORE
    reason: >-
      Cytoplasmic location is consistent with PGAM2 biology, but "ooplasm" is an
      orthology-derived tissue-specific location not relevant to the muscle isoform's
      core role; retained as non-core rather than removed.
    supported_by:
    - reference_id: Reactome:R-HSA-71445
      supporting_text: "Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate"
- term:
    id: GO:0006094
    label: gluconeogenesis
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70263
  qualifier: involved_in
  review:
    summary: >-
      Reactome pathway annotation placing the reversible phosphoglycerate mutase
      reaction within gluconeogenesis. The reaction is genuinely part of the
      gluconeogenic sequence (a reverse-of-glycolysis step).
    action: KEEP_AS_NON_CORE
    reason: >-
      The PGAM reaction participates in the gluconeogenesis pathway as modeled by
      Reactome, so the annotation is not wrong; however gluconeogenesis is a
      liver/kidney process (PGAM1), so it is not the core physiological role of the
      muscle PGAM2 isoform. Retained as non-core.
    supported_by:
    - reference_id: Reactome:R-HSA-70263
      supporting_text: "Gluconeogenesis is confined to cells of the liver and kidney"
- term:
    id: GO:0061621
    label: canonical glycolysis
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70171
  qualifier: involved_in
  review:
    summary: >-
      Reactome pathway annotation placing PGAM within canonical glycolysis (the
      cytosolic glucose-to-pyruvate route). Core process for PGAM2.
    action: ACCEPT
    reason: >-
      Authoritative pathway (TAS) annotation for the core glycolytic role; consistent
      with all other glycolysis evidence.
    supported_by:
    - reference_id: Reactome:R-HSA-70171
      supporting_text: "The reactions of glycolysis (e.g., van Wijk and van Solinge 2005) convert"
- term:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  evidence_type: EXP
  original_reference_id: PMID:4827367
  qualifier: enables
  review:
    summary: >-
      Experimental annotation of phosphoglycerate mutase activity based on
      characterization of the human PGAM isozymes as tissue-differentiation markers
      (Omenn & Cheung 1974), which established the muscle (M) versus brain (B) subunit
      isozyme system.
    action: ACCEPT
    reason: >-
      Experimental support for the core catalytic activity of the muscle
      phosphoglycerate mutase isozyme; foundational isozyme-characterization work.
    supported_by:
    - reference_id: PMID:4827367
      supporting_text: "Phosphoglycerate mutase isozyme marker for tissue differentiation in man."
- term:
    id: GO:0005654
    label: nucleoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Human Protein Atlas immunofluorescence (IDA) reporting nucleoplasmic signal.
      PGAM2 is an abundant soluble cytosolic enzyme; nucleoplasmic staining is not
      linked to any established nuclear function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      A single-technique IF localization for an abundant cytosolic glycolytic enzyme,
      without a corresponding nuclear function; likely reflects the diffuse
      distribution/permeabilization artifacts common for soluble enzymes rather than a
      core nucleoplasmic role.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- SUBUNIT: Homodimer. Interacts with ENO1. {ECO:0000250|UniProtKB:O70250,"
- term:
    id: GO:0004082
    label: bisphosphoglycerate mutase activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      Sequence-similarity transfer (from PGAM1, P18669) of the minor
      bisphosphoglycerate mutase activity. Consistent with the UniProt-documented
      reduced-activity side reaction of the BPG-dependent PGAM subfamily.
    action: ACCEPT
    reason: >-
      Genuine secondary catalytic activity supported by family membership and the
      UniProt catalytic-activity record (EC 5.4.2.4); appropriately marked as a
      similarity-based inference.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC       3-phospho-glyceroyl phosphate, but with a reduced activity."
- term:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      Sequence-similarity transfer (from PGAM1, P18669) of the core phosphoglycerate
      mutase activity. Duplicate of the well-supported core MF.
    action: ACCEPT
    reason: >-
      Correct core molecular function; the ISS inference agrees with experimental,
      phylogenetic, and automated evidence.
    supported_by:
    - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
      supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:23533145
  qualifier: located_in
  review:
    summary: >-
      High-throughput proteomic detection in exosomes from expressed prostatic
      secretions in urine. PGAM2 is a ubiquitous soluble cytosolic enzyme that
      commonly co-purifies in exosome/secretome proteomes.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      A single high-throughput exosome-proteome detection does not establish
      extracellular exosome as a functional location for this cytosolic glycolytic
      enzyme; frequent contaminant in such datasets.
    supported_by:
    - reference_id: PMID:23533145
      supporting_text: "In-depth proteomic analyses of exosomes isolated from expressed prostatic"
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: HDA
  original_reference_id: PMID:21630459
  qualifier: located_in
  review:
    summary: >-
      High-throughput proteomic detection of PGAM in isolated human sperm nuclei.
      Nuclear detection of an abundant soluble glycolytic enzyme in a whole-organelle
      proteome does not establish a functional nuclear role.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Proteomic co-detection in a sperm-nucleus preparation is prone to soluble-enzyme
      carryover; there is no established nuclear function for PGAM2, so this is an
      over-annotation of its core cytosolic biology.
    supported_by:
    - reference_id: PMID:21630459
      supporting_text: "sperm nuclei were obtained "
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71445
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS annotation of the cytosol as the location where PGAM dimers
      isomerise 2PG to 3PG. Core, correct location.
    action: ACCEPT
    reason: >-
      Authoritative pathway annotation of the correct compartment for a cytosolic
      glycolytic enzyme.
    supported_by:
    - reference_id: Reactome:R-HSA-71445
      supporting_text: "Cytosolic phosphoglycerate mutase dimers (PGAM1,2) catalyze the reversible isomerisation of 2- and 3-phosphoglycerate"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71654
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS annotation of the cytosol as the location where PGAM dimers
      isomerise 3PG to 2PG. Core, correct location (duplicate direction of the same
      reversible reaction).
    action: ACCEPT
    reason: >-
      Authoritative pathway annotation of the correct cytosolic compartment.
    supported_by:
    - reference_id: Reactome:R-HSA-71654
      supporting_text: "Cytosolic phosphoglycerate mutase catalyzes the reversible isomerisation"
- term:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  evidence_type: IMP
  original_reference_id: PMID:6262916
  qualifier: enables
  review:
    summary: >-
      Experimental (IMP) support from the first described human muscle
      phosphoglycerate mutase deficiency: muscle PGAM activity was reduced to 5.7% of
      the lowest control value, with the residual activity being the brain (BB)
      isoenzyme, implicating loss of the M subunit encoded by PGAM2.
    action: ACCEPT
    reason: >-
      Direct genetic/biochemical evidence in humans that PGAM2 provides
      phosphoglycerate mutase activity in muscle; the disease phenotype tracks the
      loss of M-subunit activity.
    supported_by:
    - reference_id: PMID:6262916
      supporting_text: "Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest"
- term:
    id: GO:0006096
    label: glycolytic process
  evidence_type: IMP
  original_reference_id: PMID:6262916
  qualifier: involved_in
  review:
    summary: >-
      Experimental (IMP) support that PGAM2 functions in glycolysis: the muscle PGAM
      deficiency produces a block at the phosphoglycerate mutase step of glycolysis
      while all other glycolytic enzymes had normal activities.
    action: ACCEPT
    reason: >-
      Human loss-of-function evidence directly linking PGAM2 to the glycolytic
      process; the specific enzymatic block defines its glycolytic role.
    supported_by:
    - reference_id: PMID:6262916
      supporting_text: "All of the other enzymes of glycolysis "
- term:
    id: GO:0006941
    label: striated muscle contraction
  evidence_type: IMP
  original_reference_id: PMID:6262916
  qualifier: involved_in
  review:
    summary: >-
      Annotation to striated muscle contraction derived from the muscle PGAM
      deficiency phenotype (exercise intolerance, cramps, pigmenturia). PGAM2 is a
      glycolytic enzyme, not a component of the contractile apparatus.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Exercise intolerance and cramps in PGAM deficiency are downstream consequences
      of impaired muscle glycolytic ATP supply, not evidence that PGAM2 participates
      directly in the muscle-contraction process; the causal role is glycolysis. This
      is an over-annotation of a phenotype (retained rather than removed as it derives
      from an experimental report).
    supported_by:
    - reference_id: PMID:6262916
      supporting_text: "intolerance for strenuous exercise and "
core_functions:
- description: >-
    Catalyzes the reversible, 2,3-bisphosphoglycerate-dependent interconversion of
    3-phosphoglycerate and 2-phosphoglycerate via a phospho-histidine intermediate,
    the eighth step of glycolysis, in the cytosol of skeletal and cardiac muscle.
  molecular_function:
    id: GO:0004619
    label: phosphoglycerate mutase activity
  directly_involved_in:
  - id: GO:0006096
    label: glycolytic process
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: file:human/PGAM2/PGAM2-uniprot.txt
    supporting_text: "CC   -!- FUNCTION: Catalyzes the interconversion of 3- and 2-phosphoglycerate"
  - reference_id: PMID:6262916
    supporting_text: "Muscle phosphoglycerate mutase activity was decreased (5.7 percent of the lowest"
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:21630459
  title: Proteomic characterization of the human sperm nucleus.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Sperm-nucleus proteome; PGAM detected as one of 403 proteins. Supports the
      nucleus HDA localization but is a high-throughput co-detection with no
      functional nuclear role; over-annotation for a cytosolic enzyme.
- id: PMID:23533145
  title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
    secretions in urine.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Exosome proteome from prostatic secretions; PGAM detected as a high-throughput
      co-purifying protein. Supports the exosome HDA localization only; over-annotation.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      BioPlex 2.0 AP-MS interactome; source of a PGAM2-BPGM protein-binding IPI.
      Supports only generic protein binding, not a specific molecular function.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      HuRI binary (Y2H) interactome; source of protein-binding IPIs and the PGAM2
      self-interaction (identical protein binding), consistent with the homodimer.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      BioPlex 3.0 AP-MS interactome; source of a PGAM2-BPGM protein-binding IPI.
      Generic protein binding only.
- id: PMID:4827367
  title: Phosphoglycerate mutase isozyme marker for tissue differentiation in man.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Foundational characterization of human PGAM isozymes (M vs B subunits) as
      tissue-differentiation markers; underpins the EXP phosphoglycerate mutase
      activity annotation.
- id: PMID:6262916
  title: 'Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic
    myopathy.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      First description of human muscle PGAM deficiency (GSD X): muscle PGAM activity
      5.7% of control, residual activity is BB isozyme, implicating the M subunit.
      Directly supports the core catalytic and glycolytic roles of PGAM2; the
      muscle-contraction annotation from this paper is a downstream phenotype.
- id: Reactome:R-HSA-70171
  title: Glycolysis
  findings: []
- id: Reactome:R-HSA-70263
  title: Gluconeogenesis
  findings: []
- id: Reactome:R-HSA-71445
  title: PGAM dimers isomerise 2PG to 3PG
  findings: []
- id: Reactome:R-HSA-71654
  title: PGAM dimers isomerise 3PG to 2PG
  findings: []
- id: file:human/PGAM2/PGAM2-uniprot.txt
  title: UniProt entry P15259 (PGAM2_HUMAN)
  findings: []